Seventure Partners — 2022 Investments
5 investments dated 2022 · listed companies and verified rows first · show all
BiotechDavis, US
Steven Watkins(Executive Officer, Director, Promoter)inCarlito Lebrilla(Director, Promoter)
Co-investorsArgonautic VenturesiSelect FundAcre Venture PartnersCollaborative FundLeaps by BayerMitsui & Co+1 more
Citalid provides a cyber risk quantification platform that translates cybersecurity threats and vulnerabilities into financial metrics and monetary impact assessments for enterprise decision-makers.
AI & Machine LearningCybersecurityEnterprise SoftwareInsurTechSaaSParis, FR
Maxime Cartan(Co-founder and CEO)inAlexandre Dieulangard(Co-founder and COO)
Co-investorsAxeleo Capital
Domain Therapeutics is a clinical-stage biopharmaceutical company developing GPCR-targeting therapies to address unmet medical needs in immuno-oncology and inflammation.
BiotechDigital Health
Co-investors3B Future Health FundCTI Life Sciences Fund L.P.adMare BioInnovationsOmnes CapitalPanacea Venture
Hardloop is an online retailer selling outdoor and mountain sports equipment and technical apparel — including hiking, trail running, climbing, alpinism, cycling and camping gear — from a wide range of brands.
E-commerceRetail TechSports Tech
Julien JEREMIEin
Co-investorsKima Ventures
La Vie Foods produces plant-based meat substitutes including bacon, ham, sausage, meatballs, sandwiches, and tofu for consumers seeking vegetarian and vegan alternatives.
BiotechConsumerFoodTechParis, FR
Nicolas Schweitzer(CEO)inVincent Poulichet(CTO)in
Co-investorsBleu CapitalCapagroEntrepreneur FirstOyster Bay Venture CapitalPartech VenturesZintinus+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
























